459
Views
18
CrossRef citations to date
0
Altmetric
Review Article

Renal safety of Non Steroidal Anti Inflammatory Drugs (NSAIDs) in the pharmacologic treatment of patent ductus arteriosus

, , , , , & show all
Pages 50-52 | Received 03 Mar 2011, Accepted 10 May 2011, Published online: 23 Sep 2011

References

  • Aranda JV, Thomas R. Systematic review: Intravenous Ibuprofen in preterm newborns. Semin Perinatol 2006;30:114–120.
  • Fanos V, Cuzzolin L. Causes and manifestations of nephrotoxicity. In: Geary, and Schaefer. (eds.) Clinical Pediatric Nephrology. Mosby Elsevier, 2008.
  • Cataldi L, Leone R, Moretti U, De Mitri B, Fanos V, Ruggeri L, Sabatino G, et al. Potential risk factors for the development of acute renal failure in preterm newborn infants: A case-control study. Arch Dis Child Fetal Neonatal Ed 2005;90:F514–F519.
  • Cuzzolin L, Fanos V, Pinna B, di Marzio M, Perin M, Tramontozzi P, Tonetto P, Cataldi L. Postnatal renal function in preterm newborns: A role of diseases, drugs and therapeutic interventions. Pediatr Nephrol 2006;21:931–938.
  • Cuzzolin L, Dal Cerè M, Fanos V. NSAID-induced nephrotoxicity from the fetus to the child. Drug Saf 2001;24:9–18.
  • Musu M, Finco G, Antonucci R, Polati E, Sanna D, Evangelista M, Ribuffo D, Schweiger V, Fanos V. Acute nephrotoxicity of NSAID from the fetus to the adult. Eur Rev Med Pharmacol Sci 2011. (In Press).
  • Antonucci R, Cuzzolin L, Arceri A, Fanos V. Urinary prostaglandin E2 in the newborn and infant. Prostaglandins Other Lipid Mediat 2007;84:1–13.
  • Agostiniani R, Mariotti P, Cataldi L, Fanos V, Sani S, Zaccaron A, Cuzzolin L. Role of renal PGE2 in the adaptation from foetal to extrauterine life in term and preterm infants. Prostaglandins Leukot Essent Fatty Acids 2002;67:373–377.
  • Cuzzolin L, Mangiarotti P, Fanos V. Urinary PGE(2) concentrations measured by a new EIA method in infants with urinary tract infections or renal malformations. Prostaglandins Leukot Essent Fatty Acids 2001;64:317–322.
  • Benini D, Fanos V, Cuzzolin L, Tatò L. In utero exposure to nonsteroidal anti-inflammatory drugs: Neonatal renal failure. Pediatr Nephrol 2004;19:232–234.
  • Fanos V, Benini D, Verlato G, Errico G, Cuzzolin L. Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus. Fundam Clin Pharmacol 2005;19:187–193.
  • Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2010;CD003481.
  • Vieux R, Desandes R, Boubred F, Semama D, Guillemin F, Buchweiller MC, Fresson J, Hascoet JM. Ibuprofen in very preterm infants impairs renal function for the first month of life. Pediatr Nephrol 2010;25:267–274. Epub 2009 Nov 10.
  • Antonucci R, Cuzzolin L, Arceri A, Dessì A, Fanos V. Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus. Eur J Clin Pharmacol 2009;65:223–230.
  • Longini M, Perrone S, Vezzosi P, Proietti F, Marzocchi B, Buonocore G, Fanos V, et al. Isoprostane levels in urine of preterm newborns treated with ibuprofen for patent ductus arteriosus closure. Pediatr Nephrol 2011;26:105–109.
  • Hasan J, Beharry KD, Gharraee Z, Stavitsky Y, Abad-Santos P, Abad-Santos M, Aranda JV, Modanlou HD. Early postnatal ibuprofen and indomethacin effects in suckling and weanling rat kidneys. Prostaglandins Other Lipid Mediat 2008;85:81–88.
  • Sáez F, Reverte V, Salazar F, Castells MT, Llinás MT, Salazar FJ. Hypertension and sex differences in the age-related renal changes when cyclooxygenase-2 activity is reduced during nephrogenesis. Hypertension 2009;53:331–337.
  • Boubred F, Vendemmia M, Garcia-Meric P, Buffat C, Millet V, Simeoni U. Effects of maternally administered drugs on the fetal and neonatal kidney. Drug Saf 2006;29:397–419.
  • Zaffanello M, Brugnara M, Bruno C, Franchi B, Talamini G, Guidi G, Cataldi L, Biban P, Mella R, Fanos V. Renal function and volume of infants born with a very low birth-weight: A preliminary cross-sectional study. Acta Paediatr 2010;99:1192–1198. Epub 2010 Mar 14.
  • Hirt D, Van Overmeire B, Treluyer JM, Langhendries JP, Marguglio A, Eisinger MJ, Schepens P, Urien S. An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic study. Br J Clin Pharmacol 2008;65:629–636.
  • Fanos V, Antonucci R, Zaffanello M. Ibuprofen and acute kidney injury in the newborn. Turk J Pediatr 2010;52:231–238.
  • Atzori L, Antonucci R, Barberini L, Griffin JL, Fanos V. Metabolomics: A new tool for the neonatologist. J Matern Fetal Neonatal Med 2009;22 Suppl 3:50–53.
  • Atzori L, Antonucci R, Barberini L, Locci E, Marincola FC, Scano P, Cortesi P, Agostiniani R, Defraia R, Weljie A, Gazzolo D, Lai A, Fanos V. 1H NMR-based metabolomic analysis of urine from preterm and term neonates. Front Biosci (Elite Ed) 2011;3:1005–1012.
  • Fanos V, Barberini L, Antonucci R, Atzori L. Metabolomics in Neonatology and Pediatrics. Clin Biochemistry 2011;7:452–454.
  • Fanos V, Guimarâes H. Present and future of European neonatology: Focus on patent ductus arteriosus. J Matern Fetal Neonatal Med 2009;22 Suppl 3:1–2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.